Bruker BRKR
NASDAQ BRKR
$59.94 +1.28 (+2.19%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bruker (BRKR) Cash from Investing Activities (2010 - 2026)

Bruker's (BRKR) quarterly Cash from Investing Activities came in at -$39.7 million in Q1 2026, down 52.11% YoY from -$82.9 million in Q1 2025, and up 28.47% on a QoQ basis from -$55.5 million in Q4 2025.

Bruker (BRKR) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Bruker (BRKR) has 17 years of Cash from Investing Activities data on file, last reported at -$39.7 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 52.11% year-over-year to -$39.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210.1 million (up 85.8% YoY) and the FY2025 annual result came in at -$196.5 million, up 88.82% from the prior year.
  • Cash from Investing Activities advanced to -$39.7 million in Q1 2026, from -$55.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $57.1 million in Q2 2022 to a low of -$1.3 billion in Q2 2024.
  • A 5-year average of -$151.2 million and a median of -$60.6 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 179.97% — and 2024, when it sank 4995.77%.
  • Tracing BRKR's Cash from Investing Activities over 5 years: stood at -$149.3 million in 2022, then jumped by 75.35% to -$36.8 million in 2023, then tumbled by 64.67% to -$60.6 million in 2024, then climbed by 8.42% to -$55.5 million in 2025, then grew by 28.47% to -$39.7 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$39.7 million (Q1 2026), -$55.5 million (Q4 2025), and -$23.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -673.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -22.08 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -108.50 Mn
10 Bruker 9.13 Bn 9.13 Bn 416.00 Mn -25.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.30 Mn
Jun 30, 2026 -25.30 Mn
Mar 31, 2026 -39.70 Mn
Mar 31, 2026 -39.70 Mn
Dec 31, 2025 -55.50 Mn
Dec 31, 2025 -55.50 Mn
Sep 30, 2025 -23.80 Mn
Sep 30, 2025 -23.80 Mn
Jun 30, 2025 -91.10 Mn
Jun 30, 2025 -91.10 Mn
Mar 31, 2025 -26.10 Mn
Mar 31, 2025 -26.10 Mn
Dec 31, 2024 -60.60 Mn
Dec 31, 2024 -60.60 Mn
Sep 30, 2024 -67.60 Mn
Sep 30, 2024 -67.60 Mn
Jun 30, 2024 -1.32 Bn
Jun 30, 2024 -1.32 Bn
Mar 31, 2024 -304.20 Mn
Mar 31, 2024 -304.20 Mn